Renal osteodystrophy in children: A systemic disease associated with cardiovascular manifestations

Growth Hormone and IGF Research

Volumn 16, Issue SUPPL., 2006, Pages 79-83

  Langman, Craig B ^a   Brooks, Ellen R ^a  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

Cardiovascular disease; Chronic kidney disease; Growth disorders; Growth hormone; Renal osteodystrophy; Vitamin D; Vitamin D analogues

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; CALCIUM DERIVATIVE; LANTHANUM; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; SEVELAMER; VITAMIN D; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY RISK; DIETARY INTAKE; EPIDEMIC; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART PROTECTION; HUMAN; METABOLITE; MORBIDITY; MORTALITY; NONHUMAN; NUTRITIONAL DISORDER; PARATHYROID HORMONE BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; RISK FACTOR; SECONDARY HYPERPARATHYROIDISM; UNITED STATES; VITAMIN D DEFICIENCY;

CARDIOVASCULAR DISEASES; CHILD; HUMANS; NUTRITION PHYSIOLOGY; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; RENAL INSUFFICIENCY, CHRONIC; RENAL OSTEODYSTROPHY; VITAMIN D DEFICIENCY;

EID: 33745216469     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2006.03.003     Document Type: Article

References (26)

1. Martin K.J., Olgaard K., Coburn J.W., et al., and the Bone Turnover Work Group. Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy. Am. J. Kidney Dis. 43 (2004) 558-565
2. Klaus G., Watson A., Edefonti A., et al. Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatr. Nephrol. 21 2 (2006) 151-159
3. K/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease, Am. J. Kidney Dis. 46 (Suppl. 1) (2005) 1-121.
4. Levey A.S., Eckardt K.U., Tsukamoto Y., et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 67 (2005) 2089-2100
5. Hogg R.J., Furth S., Lemley K.V., et al. National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 111 (2003) 1416-1421
6. Coresh J., Astor B.C., Greene T., Eknoyan G., and Levey A.S. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am. J. Kidney Dis. 41 (2003) 1-12
7. Foley R.N., Parfrey P.S., and Sarnak M.J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am. J. Kidney Dis. 32 5 Suppl. 3 (1998) S112-S119
8. Anavekar N.S., McMurray J.J., Velazquez E.J., et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N. Engl. J. Med. 351 (2004) 1285-1295
9. US Renal Data System, USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2005.
10. Goodman W.G., Goldin J., Kuizon B.D., et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N. Engl. J. Med. 342 (2000) 1478-1483
11. M.F. Holick, Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease, Am. J. Clin. Nutr. 80 (Suppl. 6) (2004) 1678S-1688S.
12. US Department of Health and Human Services. Bone Health and Osteoporosis: A Report of the Surgeon General. US Department of Health and Human Services, Office of the Surgeon General, Rockville, MD, 2004, p. 257.
13. Moore C., Murphy M.M., Keast D.R., and Holick M.F. Vitamin D intake in the United States. J. Am. Diet. Assoc. 104 (2004) 980-983
14. Takemoto F., Shinki T., Yokoyama K., et al. Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats. Kidney Int. 64 (2003) 414-420
15. Martinez I., Saracho R., Montenegro J., and Llach F. The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure. Am. J. Kidney Dis. 29 (1997) 496-502
16. Levin A., and Li Y.C. Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease?. Kidney Int. 68 (2005) 1973-1981
17. Li Y.C., Qiao G., Uskokovic M., Xiang W., Zheng W., and Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J. Steroid Biochem. Mol. Biol. 89-90 (2004) 387-392
18. Holick M.F. The vitamin D epidemic and its health consequences. J. Nutr. 135 (2005) 2739S-2748S
19. Resnick L.M., Nicholson J.P., and Laragh J.H. Calcium metabolism in essential hypertension: relationship to altered renin system activity. Fed. Proc. 45 (1986) 2739-2745
20. Kim H.W., Park C.W., Shin Y.S., et al. Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis. Nephron Clin. Pract. 102 (2005) c21-c29
21. Coburn J.W. An update on vitamin D as related to nephrology practice: 2003. Kidney Int. Suppl. 87 (2003) S125-S130
22. Cunningham J., Danese M., Olson K., Klassen P., and Chertow G.M. Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int. 68 (2005) 1793-1800
23. J.R. Wu-Wong, M. Nakane, J. Ma, X. Ruan, P.E. Kroeger, Effects of vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells, Atherosclerosis (2005) August 8 (Epub ahead of print).
24. Chertow G.M., Burke S.K., Raggi P., and and the Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 62 (2002) 245-252
25. Langman C.B. Renal osteodystrophy: a pediatric perspective, 2005. Growth Horm. IGF Res. 15 Suppl. A (2005) 42-47
26. Svensson J., Tivesten A., and Isgaard J. Growth hormone and the cardiovascular function. Minerva Endocrinol. 30 (2005) 1-13